These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 856704)

  • 21. Antidepressants and suicidal risk.
    Müller-Oerlinghausen B; Berghöfer A
    J Clin Psychiatry; 1999; 60 Suppl 2():94-9; discussion 111-6. PubMed ID: 10073395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for managing depression complicated by bipolar disorder, suicidal ideation, or psychotic features.
    Hartmann PM
    J Am Board Fam Pract; 1996; 9(4):261-9. PubMed ID: 8829075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug treatment of depression: a classification system for agent selection.
    Zisook S; Hall RC; Gammon E
    Postgrad Med; 1980 May; 67(5):153-6, 159, 161. PubMed ID: 6103532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversies in the Pharmacotherapy of Adolescent Depression.
    Masi G
    Curr Pharm Des; 2022; 28(24):1975-1984. PubMed ID: 35619257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of chemotherapy as anti-suicidal prophylaxis.
    Singh AN
    Int J Clin Pharmacol; 1974 Jan; 9(1):32-6. PubMed ID: 4150163
    [No Abstract]   [Full Text] [Related]  

  • 26. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suicidal behavior and prophylactic lithium treatment of major mood disorders: a review of reviews.
    Schou M
    Suicide Life Threat Behav; 2000; 30(3):289-93. PubMed ID: 11079641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial.
    Girlanda F; Cipriani A; Agrimi E; Appino MG; Barichello A; Beneduce R; Bighelli I; Bisoffi G; Bisogno A; Bortolaso P; Boso M; Calandra C; Cascone L; Castellazzi M; Corbascio C; Parise VF; Gardellin F; Gennaro D; Hanife B; Lintas C; Lorusso M; Luca A; Luca M; Luchetta C; Lucii C; Maio F; Marsilio A; Mattei C; Moretti D; Nosè M; Occhionero G; Papanti D; Pecile D; Percudani M; Prestia D; Purgato M; Restaino F; Romeo S; Sciarma T; Strizzolo S; Tamborini S; Todarello O; Tozzi F; Ziero S; Zotos S; Barbui C
    BMC Res Notes; 2014 Oct; 7():731. PubMed ID: 25326163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychopharmacologic drugs and prevention of suicide].
    Pöldinger W
    Wien Med Wochenschr; 1968 May; 118(20):471-8. PubMed ID: 5702499
    [No Abstract]   [Full Text] [Related]  

  • 30. [The drug therapy of depression with particular consideration of suicide prophylaxis].
    Poeldinger W
    Schweiz Arch Neurol Neurochir Psychiatr; 1966; 98(2):304-12. PubMed ID: 5985135
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression.
    Benedetti F; Riccaboni R; Locatelli C; Poletti S; Dallaspezia S; Colombo C
    J Clin Psychiatry; 2014 Feb; 75(2):133-40. PubMed ID: 24345382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of endogenous depressions using psychopharmacologic agents].
    Kielholz P; Pöldinger W
    Dtsch Med Wochenschr; 1968 Apr; 93(14):701-4. PubMed ID: 5660916
    [No Abstract]   [Full Text] [Related]  

  • 33. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention.
    Wasserman D; Rihmer Z; Rujescu D; Sarchiapone M; Sokolowski M; Titelman D; Zalsman G; Zemishlany Z; Carli V;
    Eur Psychiatry; 2012 Feb; 27(2):129-41. PubMed ID: 22137775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant drug use and suicide prevention.
    Isacsson G; Rich CL
    Int Rev Psychiatry; 2005 Jun; 17(3):153-62. PubMed ID: 16194786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suicide and antidepressants.
    Montgomery SA
    Ann N Y Acad Sci; 1997 Dec; 836():329-38. PubMed ID: 9616807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressants in the elderly.
    Chiu HF
    Int J Clin Pract; 1997 Sep; 51(6):369-74. PubMed ID: 9489065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Depressions. Picture of the disease and current therapy].
    Hausotter W
    Med Monatsschr Pharm; 2000 Nov; 23(11):353-60. PubMed ID: 11103588
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of suicide in depression and its implication for psychopharmacological treatment.
    Kasper S; Schindler S; Neumeister A
    Int Clin Psychopharmacol; 1996 Jun; 11(2):71-9. PubMed ID: 8803644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological impact of antidepressant and antipsychotic drugs on the general population.
    Barbui C; Percudani M
    Curr Opin Psychiatry; 2006 Jul; 19(4):405-10. PubMed ID: 16721172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy resistant depressions. Methodological problems. Contributions to methodical questions and animal-experimental aspects.
    Pichot P
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):80-4. PubMed ID: 4438427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.